{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:08:12Z","timestamp":1790726892579,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Southeast Asia"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.lansea.2026.100817","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T11:25:19Z","timestamp":1784114719000},"page":"100817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Kyasanur Forest Disease: feasible strategies for vaccine development and evaluation"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1720-7628","authenticated-orcid":false,"given":"Manoj V.","family":"Murhekar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeromie Wesley Vivian","family":"Thangaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak Y.","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8946-3842","authenticated-orcid":false,"given":"Gudadappa S.","family":"Kasabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nivedita","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0861-7166","authenticated-orcid":false,"given":"Pragya","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lansea.2026.100817_bib1","first-page":"341","article-title":"Kyasanur Forest disease: a new virus disease in India","volume":"11","author":"Work","year":"1957","journal-title":"Indian J Med Sci"},{"issue":"3","key":"10.1016\/j.lansea.2026.100817_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/rmv.495","article-title":"Kyasanur forest disease: an epidemiological view in India","volume":"16","author":"Pattnaik","year":"2006","journal-title":"Rev Med Virol"},{"issue":"1","key":"10.1016\/j.lansea.2026.100817_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s40475-016-0067-1","article-title":"Recent scenario of emergence of Kyasanur forest disease in India and public health importance","volume":"3","author":"Mourya","year":"2016","journal-title":"Curr Trop Med Rep"},{"issue":"3","key":"10.1016\/j.lansea.2026.100817_bib4","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4103\/ijmr.IJMR_532_21","article-title":"Experiences of Indian Council of Medical Research with tick-borne zoonotic infections: Kyasanur Forest disease & Crimean-Congo haemorrhagic fever in India with One Health focus","volume":"153","author":"Mourya","year":"2021","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.lansea.2026.100817_bib6","first-page":"152","article-title":"Field evaluation of formalin-inactivated Kyasanur Forest disease vaccine","volume":"99","author":"Dandawate","year":"1994","journal-title":"Indian J Med Res"},{"issue":"1","key":"10.1016\/j.lansea.2026.100817_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002025","article-title":"Coverage and effectiveness of Kyasanur forest disease (KFD) vaccine in Karnataka, South India, 2005\u201310","volume":"7","author":"Kasabi","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lansea.2026.100817_bib8","first-page":"146","article-title":"Kyasanur forest disease outbreak and vaccination strategy. Shimoga district, India","volume":"2014","author":"Kiran","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"10.1016\/j.lansea.2026.100817_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226141","article-title":"Kyasanur Forest Disease vaccination coverage and its perceived barriers in Goa, India\u2014a mixed methods operational research","volume":"14","author":"Oliveira","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lansea.2026.100817_bib11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41541-021-00416-2","article-title":"A live-attenuated viral vector vaccine protects mice against lethal challenge with Kyasanur Forest disease virus","volume":"6","author":"Bhatia","year":"2021","journal-title":"NPJ Vaccines"},{"issue":"36","key":"10.1016\/j.lansea.2026.100817_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj1428","article-title":"Single-dose VSV-based vaccine protects against Kyasanur Forest disease in nonhuman primates","volume":"9","author":"Bhatia","year":"2023","journal-title":"Sci Adv"},{"key":"10.1016\/j.lansea.2026.100817_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2026.1786057","article-title":"Development of whole virion inactivated Kyasanur Forest Disease vaccine candidate and its preclinical safety and efficacy evaluation","volume":"17","author":"Sunagar","year":"2026","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.lansea.2026.100817_bib15","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3390\/vaccines10030368","article-title":"Vaccine licensure in the absence of human efficacy data","volume":"10","author":"Finch","year":"2022","journal-title":"Vaccines"},{"issue":"10068","key":"10.1016\/j.lansea.2026.100817_bib16","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola \u00c7a Suffit!)","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.lansea.2026.100817_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40249-015-0066-9","article-title":"On the transmission pattern of Kyasanur Forest disease (KFD) in India","volume":"4","author":"Murhekar","year":"2015","journal-title":"Infect Dis Poverty"},{"issue":"6","key":"10.1016\/j.lansea.2026.100817_bib18","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.83527","article-title":"Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virus","volume":"2","author":"Roques","year":"2017","journal-title":"JCI Insight"},{"issue":"10394","key":"10.1016\/j.lansea.2026.100817_bib19","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/S0140-6736(23)00641-4","article-title":"Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial","volume":"401","author":"Schneider","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.lansea.2026.100817_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-72205-1","article-title":"Dynamics of human B and T cell adaptive immune responses to Kyasanur Forest disease virus infection","volume":"10","author":"Devadiga","year":"2020","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.lansea.2026.100817_bib22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/vim.2023.0107","article-title":"Cellular immune responses against \u03b3-Inactivated antigen in the recovered cases of Kyasanur Forest disease","volume":"37","author":"Kaushal","year":"2024","journal-title":"Viral Immunol"},{"issue":"2","key":"10.1016\/j.lansea.2026.100817_bib23","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4103\/ijmr.IJMR_1929_17","article-title":"Kinetics of viral RNA, immunoglobulin-M & G antibodies in Kyasanur forest disease","volume":"150","author":"Yadav","year":"2019","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.lansea.2026.100817_bib24","first-page":"1","article-title":"Persistance of humoral immunity in Kyasanur forest disease","volume":"73","author":"Achar","year":"1981","journal-title":"Indian J Med Res"},{"issue":"1","key":"10.1016\/j.lansea.2026.100817_bib25","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2025.2580154","article-title":"Pathogenicity and virulence of Kyasanur Forest disease: a comprehensive review of an expanding zoonotic threat in southwestern India","volume":"16","author":"Kaushal","year":"2025","journal-title":"Virulence"},{"issue":"1","key":"10.1016\/j.lansea.2026.100817_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67599-x","article-title":"Study of Kyasanur forest disease viremia, antibody kinetics, and virus infection in target organs of Macaca radiata","volume":"10","author":"Patil","year":"2020","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.lansea.2026.100817_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21645515.2017.1285472","article-title":"Japanese encephalitis vaccines: immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease","volume":"13","author":"Hegde","year":"2017","journal-title":"Hum Vaccin Immunother"},{"issue":"11","key":"10.1016\/j.lansea.2026.100817_bib28","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S1473-3099(21)00567-3","article-title":"India's COVID-19 vaccination drive: key challenges and resolutions","volume":"21","author":"Choudhary","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.lansea.2026.100817_bib30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/EDE.0000000000001116","article-title":"The use of test-negative controls to monitor vaccine effectiveness: a systematic review of methodology","volume":"31","author":"Chua","year":"2020","journal-title":"Epidemiology"}],"container-title":["The Lancet Regional Health - Southeast Asia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772368226001022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772368226001022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:53:07Z","timestamp":1790725987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772368226001022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":25,"alternative-id":["S2772368226001022"],"URL":"https:\/\/doi.org\/10.1016\/j.lansea.2026.100817","relation":{},"ISSN":["2772-3682"],"issn-type":[{"value":"2772-3682","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kyasanur Forest Disease: feasible strategies for vaccine development and evaluation","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Southeast Asia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lansea.2026.100817","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100817"}}